SEC Form 4 · accession 0001179110-15-005829

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior Vice President

Period of report

Mar 31, 2015

Accepted (ET)

Apr 2, 2015 · 5:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value^F3	Mar 31, 2015	A	1,042	$0.00	A	2,421	I	By spouse
Common shares without par value	Mar 31, 2015	F	99	$47.08	D	2,322	I	By spouse
Common shares without par value	Mar 31, 2015	S	228	$46.431	D	2,094	I	By spouse
Common shares without par value	holding	—	—		—	36,898	D
Common shares without par value^F1	holding	—	—		—	20	I	Profit Sharing Trust
Common shares without par value^F2	holding	—	—		—	63,903	I	Jaime Contreras Marvan 2006 Living Trust
Common shares without par value^F4	holding	—	—		—	12,081	I	Living Trust (by spouse)

No Table II lines on this filing.

F1Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2015.
F2Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
F3This grant represents a restricted stock unit award under the Abbott Laboratories 2009 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniversary of the grant date. The award includes the right to have stock withheld for tax purposes.
F4Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).